Nuwellis Investor Presentation Deck
August 2023, 29 slides
  1. Nuwellis
  2. Related Decks
  3. Investor Presentation Decks
investor presentation | Nuwellis
safe harbor statement | Nuwellis
our mission is dedicated to transforming the lives of patients suffering from fluid overload through science collaboration and innovation | Nuwellis
investment highlights | Nuwellis
executive leadership team | Nuwellis
provides a solution to millions of heart failure patients background million us adults with and will die within five years their diagnosis | Nuwellis
fluid overload is a condition where there is too much fluid in the vital organs and interstitial space leading cause of hospital | Nuwellis
diuretics significant limitations as current standard of care | Nuwellis
clinically superior solution for fluid overload saving lives time money | Nuwellis
how the system works predictable and precise fluid removal | Nuwellis
ultrafiltration positive roi clinical and economic benefits reduction in heart failure hospitalizations per year year real world experience with ultrafiltration hospital acutely hospital readmissions | Nuwellis
ultrafiltration a safe and more effective therapy than diuretics versus intravenous diuretics and hospitalizations for heart failure avoid trial adjustable ultrafiltration won more times than adjustable loop diuretics resulting in win ratios that all favored ultrafiltration over diuretics in reducing mortality and events in congested patients venue am dale pale | Nuwellis
peer reviewed publication advocates for early clinical application of ultrafiltration in diuretic resistant patients shortcomings leave a gap care | Nuwellis
collaboration announces pilot agreement with | Nuwellis
expanding use of ultrafiltration across hospital specialty units improves outcomes for fluid overloaded patients surgery transplants mid to long term sane psis advanced liver disease adult | Nuwellis
fluid overload is associated with greater mortality in post cardiac surgery patients | Nuwellis
growing pediatric business pediatric revenue has outpaced total growth over past two years | Nuwellis
providing pediatric patients with high mortality risk an opportunity at life life survival end of group traditionally do not receive any kind of therapy | Nuwellis
introducing therapy to address unmet needs of critically ill pediatric patients survival end | Nuwellis
multiple growth opportunities moving to standard of care in fluid overload tam market sales market sales market sales | Nuwellis
novel technology with strong portfolio novel patents with protection to | Nuwellis
key milestones | Nuwellis
financial snapshot annual revenue | Nuwellis
investment highlights | Nuwellis
is dedicated to transforming the lives of patients suffering from fluid overload through science collaboration and innovation | Nuwellis
appendix | Nuwellis
company history | Nuwellis
making the standard of care in fluid overload | Nuwellis
market size sources | Nuwellis
See More
Nuwellis
Investor Presentation Decks
Medical Devices Decks
Healthcare Decks
Explore Topics
Hospital
Liver
Blood
Recent decks by Nuwellis
Investor Presentation
March 2023
See all presentations by Nuwellis (2 decks)
Related decks
Theravance Biopharma
Results
May 2023
Genetron
IPO
July 2020
Enochian Biosciences
Investor Presentation
January 2024
Minerva
IPO
October 2021
Kymera
Investor Presentation
June 2023
NeuroBo Pharmaceuticals
Investor Presentation
January 2024
Bluejay
Investor Presentation
December 2023
MindMed
Investor Presentation
April 2021
Recent decks by Nuwellis
See all presentations (2 decks)
Investor Presentation
March 2023
Theravance Biopharma
Results
May 2023
Genetron
IPO
July 2020
Enochian Biosciences
Investor Presentation
January 2024
Minerva
IPO
October 2021
Kymera
Investor Presentation
June 2023
NeuroBo Pharmaceuticals
Investor Presentation
January 2024
Bluejay
Investor Presentation
December 2023
MindMed
Investor Presentation
April 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io